Punjab health authorities have issued an alert over a batch of allergy medicine after laboratory tests found it to be substandard.
According to the Directorate of Drugs Control Punjab, the Punjab Drug Testing Laboratory raised concerns about a specific batch of Hirazine 10mg, which contains cetirizine dihydrochloride, a commonly used antihistamine.
The Directorate of Drugs Control and the Punjab Provincial Quality Control Board have ordered the immediate withdrawal of batch HZT214 from the market. The batch carries an expiry date of December 2027.
Health authorities have advised patients and the public to stop using the affected batch immediately, warning that it may pose a health risk.
Pharmacies, medical stores and hospitals have also been directed to stop selling the batch and report any remaining stock to the relevant drug inspector.
The manufacturer has been instructed to recall all medicines from batch HZT214 and submit a detailed report to the Drug Regulatory Authority of Pakistan.
Get the latest news and stories wherever you prefer.
Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
Shares
